Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Presentation
May 02, 2016

Current Best Practices in Commercial Kit Evaluation and Validation for Biomarker Assays

Presented at the 10th Workshop on Recent Issues in Bioanalysis (WRIB) this presentation outlines the current best practices in commercial kit evaluation and validation for biomarker assays. Q2 Solutions has the breadth and depth of biomarker expertise, tools and capabilities to prepare and implement strategies to help drug developers effectively gain a competitive advantage – helping ensure your success in clinical trials, regulatory approvals and new product launches.   

Q2 Solutions is your partner of choice for any development program which requires identifying, designing and/or validating biomarkers, because we’re able to go a step further to help you understand how these biomarkers can help deliver actionable insights for better health™. Contact us to learn more about Q2 Solutions and how we can put our tailored solutions, delivery excellence, and shaping outcomes to work for you.
Challenges in Method Development and Validation of LC-MS Biomarker Assays

Mass Spectrometry to Enable Sensitive Quantitation of a Small Molecule Therapeutic

Overcoming Triple Quadrupole Selectivity Challenges by Use of High-Resolution Accurate Mass Spectrometry to Enable Sensitive Quantitation of a Small Molecule Therapeutic in Rabbit Plasma

Read More